Kosin Med J.  2016 Dec;31(2):97-102. 10.7180/kmj.2016.31.2.97.

The Role of Vitamin D in Menopausal Medicine

• Kim M
• Kim TH
• Lee HH
• Kim HY
• Oh MJ

• KMID: 2365234
• DOI: http://doi.org/10.7180/kmj.2016.31.2.97

Abstract

Menopause is the time at which menstruation stops in women. After menopause, women are more susceptible to some diseases, especially osteoporosis and cardiovascular disease. Vitamin D has a protective effect against osteoporosis by facilitating the absorption of calcium and affecting parathyroid hormone. Vitamin D also affects cardiovascular function by lowering the blood pressure, which affects the renin-angiotensin system and alters the low-density lipoprotein receptor activity. This paper discusses supplemental vitamin D in postmenopausal women with osteoporosis and cardiovascular disease.

Keyword

Cardiovascular disease; menopause; osteoporosis; vitamin D

MeSH Terms

Absorption
Blood Pressure
Calcium
Cardiovascular Diseases
Female
Humans
Menopause
Menstruation
Osteoporosis
Parathyroid Hormone
Receptors, Lipoprotein
Vitamin D*
Vitamins*
Calcium
Parathyroid Hormone
Receptors, Lipoprotein
Vitamin D
Vitamins

Reference

References

1. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best pract Res Clin Endocrinol Metab. 2011; 25:585–91.

2. Dong J, Lau CW, Wong S, Huang Y. Cardiovascular benefits of vitamin D. Sheng Li Xue Bao. 2014; 66:30–6.

3. Kim JS, Choi YJ, Lee KW, Song IJ, Kim CA, Son BH, et al. The study in vitamin D concentration in the blood for infants with high level of alkaline phosphatase. Kosin Med J. 2012; 27:17–24.

4. Kim TH, Lee HH, Kim JM. Letters to the Editor. Menopause. 2015; 22:797.

5. Kim TH, Lee HH, Kim JM. Comments on vitamin D. Maturitas. 2015; 81:329.

6. Han MJ, Lee JH. Factors influencing self-identity and menopausal symptoms on level of depression in middle aged women. Korean J Women Health Nurs. 2013; 19:275–84.

7. Kwak EK, Park HS, Kang NM. Menopause knowledge, attitude, symptom and management among midlife employed women. J Menopausal Med. 2014; 20:118–25.

8. LeBlanc ES, Hedlin H, Qin F, Desai M, Wactawski-Wende J, Perrin N, et al. Calcium and vitamin D supplementation do not influence menopause-related symptoms: Results of the Women's Health Initiative Trial. Maturitas. 2015; 81:377–83.

9. Kim HY, Kong EH. The Association between serum GGT level and bone mineral density in postmenopausal women. Kosin Med J. 2013; 28:35–41.

10. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22:477–501.

11. Limpaphayom KK, Kim HY. Diagnosis and treatment of osteoporosis. Kosin Med J. 2011; 26:121–6.

12. Choi SH, Lee DJ, Kim KM, Kim BT. Association between seasonal changes in vitamin D and bone mineral density. J Korean Soc Menopause. 2011; 17:88–93.

13. Cândido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014; 15:6569–91.

14. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009; 94:1244–50.

15. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354:669–83.

16. Robbins JA, Aragaki A, Crandall CJ, Manson JE, Carbone L, Jackson R, et al. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy. Menopause. 2014; 21:116–23.

17. Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, et al. Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial. J Acad Nutr Diet. 2013; 113:1302–10.

18. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21:82–91.

19. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014; 114:379–93.

20. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89–90:387–92.

21. Li YC. Vitamin D regulation of the renin–angio-tensin system. J Cell Biochem. 2003; 88:327–31.

22. Pérez-López FR. Vitamin D metabolism and cardiovascular risk factors in postmenopausal women. Maturitas. 2009; 62:248–62.

23. Kim TH, Park J, Lee HH, Lee WS, Chung SH, Park Y, et al Expression of vitamin D receptor by pulse consumption in the uterus of menopausal mouse model. J Korean Soc Menopause. 2013; 19:1–8.

24. Kim TH, Lee HH, Park J. Immunohistochemical detection of the 1,25-dihydroxy vitamin D receptor in the human vagina. Iran J Reprod Med. 2014; 12:805–10.

25. Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J Womens Health (Larchmt). 2013; 22:915–29.

26. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab. 2012; 97:2670–81.